M. Varughese

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

Matthew R. Sydes, Melissa Spears, Malcolm D. Mason et al. · Annals of Oncology · 2018 · 250 citations · Full text

Medicine, Oncology, Urology +17

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial

Galina Velikova, Linda Williams, Sarah Willis et al. · The Lancet Oncology · 2018 · 80 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Radiotherapy Management of Muscle Invasive Bladder Cancer: Evaluation of a National Cohort

M. Varughese, Sarah Treece, K. Drinkwater · Clinical Oncology · 2019 · 21 citations

Medicine, Oncology, Radiation Oncology +11

Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial

Robert Huddart, S. Hafeez, Roberto Alonzi et al. · Clinical Oncology · 2023 · 15 citations · Full text

Medicine, Oncology, Radiation Oncology +17